Document is current
Any future updates will be listed below
-
Authors
Treutlein, Christoph
Bäuerle, Tobias
Nagel, Armin M.
Guermazi, Ali
Kleyer, Arnd
Simon, David
Schett, Georg
Hepp, Tobias
Uder, Michael
Roemer, Frank W. https://orcid.org/0000-0001-9238-7350
- License Information
-
More Information
Article History
Received: 29 July 2019
Accepted: 7 February 2020
First Online: 21 February 2020
Ethics approval and consent to participate
: Written informed consent was obtained for this ethics board-approved investigation (Local IRB number: AZ_189_15B). (Ethics committee of the Friedrich-Alexander University Erlangen-Nürnberg).
: Not applicable.
: Dr. Guermazi has received consultancies, speaking fees, and/or honoraria from Sanofi-Aventis, Merck Serono, and TissuGene and is President and shareholder of Boston Imaging Core Lab (BICL), LLC a company providing image assessment services. Dr. Roemer is Chief Medical Officer and shareholder of BICL, LLC. None of the other authors have declared any competing interests.
